Provided by Tiger Trade Technology Pte. Ltd.

Personalis

16.40
+0.17001.05%
Post-market: 16.490.0900+0.55%18:23 EDT
Volume:3.18M
Turnover:52.06M
Market Cap:1.75B
PE:-14.94
High:16.44
Open:16.30
Low:16.12
Close:16.23
52wk High:18.89
52wk Low:4.96
Shares:107.00M
Float Shares:72.63M
Volume Ratio:1.18
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:7.46
PE(LYR):-18.01

Loading ...

Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak

Dow Jones
·
Yesterday

The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street

Dow Jones
·
Sep 04

Tempus AI Buy Rating Reiterated as Personalis Deal Strengthens MRD Platform; $80 Price Target Unchanged

TIPRANKS
·
Sep 01

Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win

Simply Wall St.
·
Aug 26

Personalis Shares Fall After Craig-Hallum Downgrade

MT Newswires Live
·
Aug 25

Craig-Hallum Downgrades Personalis to Hold From Buy, Price Target is $16.25

MT Newswires Live
·
Aug 24

Personalis downgraded to Hold from Buy at Craig-Hallum

TIPRANKS
·
Aug 24

Personalis secures new Million Veteran Program task order

TIPRANKS
·
Aug 21

Personalis - on Aug 20, Received New Task Order Under Its Contract with U.S. Department of Veterans Affairs for Va Mvp

THOMSON REUTERS
·
Aug 21

Personalis - New Task Order Effective Sept 30, 2026, Valued up to $18.30 Mln - SEC Filing

THOMSON REUTERS
·
Aug 21

Personalis Wins VA Million Veteran Program Task Order Worth up to $18.3 Million

Reuters
·
Aug 21

Personalis (PSNL) Is Up 6.1% After Q2 Revenue Rises But Losses Deepen - What's Changed

Simply Wall St.
·
Aug 07

Sanuwave Health Q2 Revenue Falls, Withdraws FY Guidance Amid Medicare Reimbursement Uncertainty

Reuters
·
Aug 07

Natera Q2 Revenue Rises Beats Estimates on Higher Overall Test Volumes, Raises 2026 Outlook

Reuters
·
Aug 07

Delcath Systems Q2 Revenue Rises, Beats Estimates

Reuters
·
Aug 06

Sweden's Immunovia Q2 Sales Rise on PancreaSure Test Uptake

Reuters
·
Aug 06

Caris Life Sciences Q2 Revenue Rises 45% on the Back of Molecular Profiling Services

Reuters
·
Aug 06

Grail Q2 Revenue Rises 26%, Net Loss Narrows 3%

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), OrthoPediatrics (KIDS) and Sight Sciences (SGHT)

TIPRANKS
·
Aug 05

Personalis, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05